Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Iris González García"'
Autor:
Betel Del Rosario García, Jonathan González García, Fernando Gutiérrez Nicolás, Iris González García, Ruth Ramos Díaz, Sunil Lakhwani Lakhwani, Ivette Mourani Padrón, María Micaela Viña Romero, Gloria Julia Nazco Casariego
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 29(1)
Introduction The addition of imatinib to the therapeutic arsenal for chronic myeloid leukaemia (CML) has changed the natural course of the disease, in such a way that it is now considered a chronic pathology. However, to achieve therapeutic success,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caff4d693a46c2bf579292df9a07e7d5
https://pubmed.ncbi.nlm.nih.gov/34661491
https://pubmed.ncbi.nlm.nih.gov/34661491
Autor:
José B. Fariña, Ana Santoveña-Estévez, Javier Suárez-González, Iris González-García, Diego Dorta-Vera, Nuria Teigell-Perez
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 3, Iss 2, Pp 59-70 (2018)
BackgroundDexamethasone is used in pediatrics mainly for treatment of croup and bronchopulmonary dysplasia. Commercially available pediatric oral formulations include inadequate excipients for this population. When there are only commercially availab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc1ee4ff0f6ff0e48c07dd921abfb28b
https://doi.org/10.1515/pthp-2018-0003
https://doi.org/10.1515/pthp-2018-0003